Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.42 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.41 |
| ▸ | FDPS | P14324 | 9/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20203168 | 0.96 | CES2 (0.40) | CES2GGPS1FDPSMEN1MAPT | |
| SCHEMBL23894886 | 0.94 | CES2 (0.37) | CES2GGPS1FDPSMEN1MAPT | |
| SCHEMBL19736033 | 0.94 | CES2 (0.41) | CES2GGPS1FDPSMEN1MAPT | |
| SCHEMBL24916372 | 0.87 | MEN1 (0.37) | CES2MEN1MAPTKMT2AATM | |
| SCHEMBL23346658 | 0.86 | MEN1 (0.36) | CES2GGPS1FDPSMEN1MAPT | |
| SCHEMBL19703834 | 0.84 | CES2 (0.35) | CES2GGPS1FDPSMEN1MAPT | |
| SCHEMBL21566927 | 0.84 | CES2 (0.35) | CES2GGPS1FDPSMEN1MAPT | |
| SCHEMBL19939441 | 0.83 | CES2 (0.42) | CES2GGPS1FDPSMEN1MAPT | |
| SCHEMBL8521468 | 0.83 | CES2 (0.42) | CES2GGPS1FDPSMEN1MAPT | |
| SCHEMBL24916255 | 0.83 | CES2 (0.39) | CES2GGPS1FDPSMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230247904-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230247904-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | NR2E3, CRY2, DRD1 | CES2 2352/4885GGPS1 3564/4885FDPS 4422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.